MedTrace Logo

Hormone Replacement Therapy (HRT) Website Tool

NCT00319072 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2006-04-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate a prototype web-based module for patients to generate appropriate and focused health information along with a customized set of questions to take to their health care provider for discussion on hormone replacement therapy.

Conditions

  • Communication
  • Menopause
  • Hormone Replacement Therapy

Interventions

BEHAVIORAL

TalkToYourDoc(sm) hormone therapy module

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Elaine Eaker, ScD · Eaker Epidemiology Enterprises, LLC

  • Vanessa M. Barnabei, MD, PhD · Medical College of Wisconsin

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-03-31
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00319072 on ClinicalTrials.gov